A

Arch Biopartners Inc (ACH:TSXV) (FOIFF:OTCBB)

5 employees

Arch Biopartners acquires and develops products and technology for sale to pharmaceutical and industrial companies.

Basic info

biotechnology research

Biotechnology

Treatments for Inflammation

Biopharma

Treating Acute Kidney Injury

Medical

Sepsis

Acute Organ Inflammation

Novel Therapeutics

2010

$750K

from 1 investors over 1 rounds

A

Arch Biopartners Inc (ACH:TSXV) (FOIFF:OTCBB) raised $750K on July 14, 2021

Investors: Canadian Institutes of Health Research | Instituts de recherche en santé du Canada